Biomarker Testing Ma rket Innovation Accelerates with Next-Gen Multiomics and Molecular Profiling

"Global Biomarker Testing market reached US$162.09 billion in 2023 and is expected to reach US$388.43 billion by 2030, growing at a CAGR of 13.3% during the forecast period 2024-2030," according to DataM Intelligence.

The market landscape is highly fragmented, with both established multinational corporations and emerging biotech firms contributing to innovation. Key companies dominating the biomarker testing market include QIAGEN N.V., Bio-Rad Laboratories, Inc., Illumina, Inc., Labcorp Drug Development, IQVIA, Inc., Quanterix Corporation, Merck KGaA, Abbott Laboratories, Thermo Fisher Scientific Inc., and Q2 Solutions, among others.

Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/biomarker-testing-market?jd

Key Mergers, Acquisitions & Partnerships Reshaping the Biomarker Testing Market

1. Waters-BD Diagnostics $17.5 B Reverse Morris Trust Merger
Waters Corporation will merge with Becton Dickinson's Biosciences & Diagnostic Solutions division, doubling Waters' addressable market to ≈ $40 billion and boosting its multiplex biomarker testing portfolio.

2. Regeneron to Acquire 23andMe for $256 M
Regeneron announced plans to buy consumer genetics leader 23andMe, aiming to integrate large-scale genomic data with its drug development and biomarker discovery programs, strengthening precision medicine capabilities

3. Renovaro Biosciences-BioSymetrics Merger
Renovaro closed its merger with AI-driven BioSymetrics to create an integrated platform for AI-powered biomarker discovery across oncology and neurology, enhancing in silico target identification and in vivo validation capacity.

These transactions highlight the sector's rapid consolidation around data-rich genomics assets, AI-enabled discovery engines, and integrated diagnostic platforms, positioning companies to accelerate companion diagnostic development and capitalize on the growing demand for precision biomarker testing worldwide.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biomarker-testing-market?jd

Key Growth Drivers & Emerging Opportunities in the Biomarker Testing Market

• Rising demand for personalized and precision medicine is driving biomarker testing across oncology, neurology, and cardiology.
• Technological advancements in genomics, proteomics, and AI-powered diagnostics are accelerating biomarker discovery and validation.
• Increased R&D investments from pharma and biotech companies are boosting the development of companion diagnostics for targeted therapies.
• Government initiatives and healthcare funding are supporting early disease detection programs using molecular biomarkers.
• Expanding applications in clinical trials, liquid biopsy, and non-invasive testing are opening new revenue streams and commercial partnerships.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biomarker-testing-market?jd

Regional Market Dynamics in the Biomarker Testing Market

North America dominates the market due to strong R&D infrastructure, FDA-approved companion diagnostics, and high adoption of personalized medicine.

Europe is witnessing steady growth driven by government-supported cancer screening programs and advancements in multi-omics technologies.

Asia-Pacific is the fastest-growing region, with increasing investments in clinical research, expanding biotech hubs, and rising demand for early disease detection.

Latin America is emerging with improved diagnostic access and public-private collaborations in genomic research.

Middle East & Africa show gradual progress through healthcare modernization and rising awareness of non-invasive biomarker tests.

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.